コロラド州における食道癌の臨床試験
コロラド州内の拠点で、食道癌に関する19件の研究が参加者を募集しています。
コロラド州内の都市
公式研究テキスト（英語）
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Sarah Cannon Research Institute at HealthOne, Denver
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06465069Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Penrose-Saint Francis Healthcare, Colorado Springs
- Rocky Mountain Cancer Centers-Penrose, Colorado Springs
- Saint Francis Cancer Center, Colorado Springs
- 他6件
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07283939Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Rocky Mountain Regional VA Medical Center, Aurora
- UCHealth University of Colorado Hospital, Aurora
- Penrose-Saint Francis Healthcare, Colorado Springs
- 他15件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Phase 1 Study of PF-08046033 in Advanced Solid Tumors
- Presbyterian/St Lukes Medical Center, Denver
- Sarah Cannon Research Institute at HealthONE, Denver
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07519655Pan-tumor MRD Study
- The Melanoma and Skin Cancer Institute, Englewood
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/24更新 · NCT06605404Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- University of Colorado Cancer Center, Aurora
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- University of Colorado Cancer Center, Aurora
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/21更新 · NCT05983432ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- University of Colorado, Aurora
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Research Site, Denver
- Research Site, Lone Tree
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07431281The Vanguard Study: Testing a New Way to Screen for Cancer
- Keefe Memorial Hospital, Cheyenne Wells
- Kaiser Permanente-Franklin, Denver
- Poudre Valley Hospital, Fort Collins
- 他5件
被験者募集中健康なボランティア歓迎
45歳〜75歳 · 全性別 · 2026/09/02更新 · NCT06995898A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
- SCRI Denver, Denver
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/27更新 · NCT07227168Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
- University of Colorado Denver, Aurora
- UCHealth Highlands Ranch Hospital, Highlands Ranch
被験者募集中観察研究健康なボランティア歓迎
18歳〜99歳 · 全性別 · 2026/08/24更新 · NCT05517811A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- Rocky Mountain Cancer Centers, Lone Tree
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/29更新 · NCT03526835A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
- Rocky Mountain Cancer Center, Littleton
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/10更新 · NCT06695845Integrated Cancer Repository for Cancer Research
- Advent Health, Greenwood Village
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Sarah Cannon Research Institute, Denver
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/06更新 · NCT06239194SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Aurora
- Massive Bio SYNERGY-AI site, Denver
- Massive Bio SYNERGY-AI site, Littleton
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- University of Colorado Cancer Center at UC Health Sciences Center, Aurora
被験者募集中観察研究
21歳〜90歳 · 全性別 · 2025/09/22更新 · NCT00900419ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。